RATIOS
Lincoln Pharmaceuticals Ltd.
BSE
Jun 16, 09:34
571.60
-13.85 ( -2.37%)
Volume
487
Prev. Close
585.45
Open Price
589.45
Bid Price(Qty.)
570.90 (17)
Offer Pr.(Qty.)
572.60 (20)
NSE
Jun 16, 09:24
579.20
-6.75 ( -1.15%)
Volume
9765
Prev. Close
585.95
Open Price
582.50
Bid Price(Qty.)
578.70 (16)
Offer Pr.(Qty.)
579.90 (8)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE405C01035
|
Market Cap. ( ₹ in Cr. )
|
1160.12
|
P/BV
|
1.81
|
Book Value ( ₹ )
|
319.16
|
|
BSE Code
|
531633
|
52 Week High/Low ( ₹ )
|
980/499
|
FV/ML
|
10/1
|
P/E(X)
|
14.09
|
|
NSE Code
|
LINCOLNEQ
|
Book Closure
|
30/09/2024
|
EPS ( ₹ )
|
41.11
|
Div Yield (%)
|
0.31
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 30.20 |
| Diluted EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 30.20 |
| Cash EPS (Rs.) | 47.55 | 51.89 | 40.97 | 38.66 | 33.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 182.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 182.48 |
| Dividend / Share (Rs.) | 1.80 | 1.80 | 1.50 | 1.50 | 1.50 |
| Revenue From Operations / Share (Rs.) | 311.15 | 289.84 | 254.78 | 235.69 | 206.53 |
| PBDIT / Share (Rs.) | 61.89 | 67.06 | 55.74 | 52.66 | 44.06 |
| PBIT / Share (Rs.) | 55.45 | 61.76 | 51.17 | 48.62 | 41.23 |
| PBT / Share (Rs.) | 54.51 | 61.03 | 50.15 | 47.89 | 40.51 |
| Net Profit / Share (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 30.20 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 19.89 | 23.13 | 21.87 | 22.34 | 21.33 |
| PBIT Margin (%) | 17.82 | 21.30 | 20.08 | 20.62 | 19.96 |
| PBT Margin (%) | 17.51 | 21.05 | 19.68 | 20.32 | 19.61 |
| Net Profit Margin (%) | 13.21 | 16.07 | 14.28 | 14.69 | 14.62 |
| Return on Networth / Equity (%) | 12.25 | 15.73 | 14.50 | 16.02 | 16.55 |
| Return on Capital Employeed (%) | 16.07 | 20.34 | 19.89 | 21.93 | 22.12 |
| Return On Assets (%) | 10.33 | 13.32 | 12.41 | 12.98 | 13.76 |
| Asset Turnover Ratio (%) | 0.83 | 0.90 | 0.91 | 0.97 | 1.02 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.71 | 4.85 | 5.09 | 3.91 | 4.17 |
| Quick Ratio (X) | 3.97 | 4.01 | 4.12 | 3.10 | 3.57 |
| Inventory Turnover Ratio (X) | 2.75 | 2.73 | 2.48 | 2.80 | 2.45 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 3.22 | 4.12 | 4.33 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 2.89 | 3.66 | 3.87 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 96.78 | 95.88 | 95.67 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 97.11 | 96.34 | 96.13 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 65.85 | 91.84 | 55.03 | 72.69 | 61.29 |
| Interest Coverage Ratio (Post Tax) (%) | 44.74 | 64.79 | 36.93 | 48.80 | 43.01 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1082.75 | 1160.22 | 646.55 | 606.63 | 437.02 |
| EV / Net Operating Revenue (X) | 1.74 | 2.00 | 1.27 | 1.28 | 1.06 |
| EV / EBITDA (X) | 8.73 | 8.64 | 5.79 | 5.75 | 4.96 |
| MarketCap / Net Operating Revenue (X) | 1.77 | 2.02 | 1.33 | 1.32 | 1.09 |
| Retention Ratios (%) | 0.00 | 96.77 | 95.87 | 95.66 | 0.00 |
| Price / BV (X) | 1.64 | 1.98 | 1.35 | 1.44 | 1.23 |
| Price / Net Operating Revenue (X) | 1.77 | 2.02 | 1.33 | 1.32 | 1.09 |
| EarningsYield | 0.07 | 0.07 | 0.10 | 0.11 | 0.13 |